As the producer of anti-insulin hormones and in its function as the foeto-maternal-interface, the placenta is thought to play a key role in the pathophysiology of GDM in general and, more specifically, in the long-term health programming of the offspring [13,14]. This evidence concerns the gene INS and gestational diabetes.